Literature DB >> 2265930

Temporal discrimination in schizophrenic and affective disorders: evidence for a dopamine-dependent internal clock.

T Rammsayer1.   

Abstract

Performance in temporal discrimination of time intervals in the range of milliseconds was compared in 80 healthy subjects, 27 patients with schizophrenic disorders, 33 patients with major depression, 21 patients with dysthymic disorders. For schizophrenic patients as well as for patients with major depression, pronounced deficits in duration discrimination could be demonstrated as compared to the healthy control group (p less than .01). Patients with dysthymic disorders and schizophrenic patients differed significantly from the melancholic group (p less than .01 and p less than .05, respectively). The results are discussed on the basis of the assumption of an internal clock, implying that the clock rate is highest and therefore temporal resolution is best with healthy subjects. With psychiatric patients performance in temporal discrimination was impaired to a slowing down in clock rate and thus decreased temporal resolution. There is strong evidence that changes in clock rate depend on the effective level of dopamine. This leads to the conclusion that temporal discrimination thresholds may be seen as an indicator for deviations from the optimal level of dopaminergic activity in psychiatric patients. In addition, possible effects due to age and medication are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265930     DOI: 10.3109/00207459008986593

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  15 in total

1.  Differential effects of clozapine and haloperidol on interval timing in the supraseconds range.

Authors:  Christopher J MacDonald; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

2.  Temporal processing in schizophrenia: effects of task-difficulty on behavioral discrimination and neuronal responses.

Authors:  Deana B Davalos; Donald C Rojas; Jason R Tregellas
Journal:  Schizophr Res       Date:  2010-08-01       Impact factor: 4.939

Review 3.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

4.  Aging and temporal discrimination of brief auditory intervals.

Authors:  T H Rammsayer; S D Lima; W H Vogel
Journal:  Psychol Res       Date:  1993

5.  Effects of practice and signal energy on duration discrimination of brief auditory intervals.

Authors:  T H Rammsayer
Journal:  Percept Psychophys       Date:  1994-04

6.  Predictive Motor Timing and the Cerebellar Vermis in Schizophrenia: An fMRI Study.

Authors:  Jan Lošák; Jitka Hüttlová; Petra Lipová; Radek Marecek; Martin Bareš; Pavel Filip; Jozef Žubor; Libor Ustohal; Jirí Vanícek; Tomáš Kašpárek
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

7.  Genetic determinants of time perception mediated by the serotonergic system.

Authors:  Olga V Sysoeva; Alexander G Tonevitsky; Jirí Wackermann
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

Review 8.  Explicit Time Deficit in Schizophrenia: Systematic Review and Meta-Analysis Indicate It Is Primary and Not Domain Specific.

Authors:  Valentina Ciullo; Gianfranco Spalletta; Carlo Caltagirone; Ricardo E Jorge; Federica Piras
Journal:  Schizophr Bull       Date:  2015-08-06       Impact factor: 9.306

9.  Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.

Authors:  Adam L Halberstadt; Ivan S Sindhunata; Kees Scheffers; Aaron D Flynn; Richard F Sharp; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-03-25       Impact factor: 5.250

Review 10.  Serotonergic hallucinogens as translational models relevant to schizophrenia.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-13       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.